🇺🇸 FDA
Patent

US 10105448

Combined enteropathogen recombinant construct

granted A61KA61K2039/55505A61K2039/6037

Quick answer

US patent 10105448 (Combined enteropathogen recombinant construct) held by United States of America as represented by the Secretary of the Air Force expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/55505, A61K2039/6037, A61K2039/70, A61K39/00